Base editing changes a letter; prime editing rewrites a short stretch. Inserting a whole gene at a chosen site is a harder problem, and US11952571B2 - "Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (PASTE)," issued April 9, 2024 to the Massachusetts Institute of Technology - claims an approach to it.
The load-bearing limitation is programmable integration of large cargo, and claim 1 assembles it from four parts in a single composition. It recites: (a) a nucleic acid encoding a DNA binding nickase domain linked to a reverse transcriptase domain; (b) a nucleic acid encoding at least two guide RNAs, each carrying, from 3' to 5', a primer binding sequence, a sequence complementary to one strand of an integration recognition sequence, and a target binding sequence; (c) a nucleic acid encoding an integration enzyme; and (d) an exogenous nucleic acid linked to an integration cognate of that recognition sequence. The novelty is the combination: a prime-editing-style nickase-reverse-transcriptase first writes a short landing site into the genome, and then a site-specific integrase drops the large cargo into that landing site - achieving site-specific large-payload insertion without relying on a double-strand break and the cell's error-prone repair.
"This disclosure provides systems, methods, and compositions for site-specific genetic engineering using Programmable Addition via Site-Specific Targeting Elements (PASTE)."- U.S. Patent No. 11,952,571 source
The dependent claims name the actual machine parts, which is where the disclosed mechanism becomes concrete. The nickase is selected from Cas9-D10A, Cas9-H840A, and Cas12a/b nickase (claim 6). The reverse transcriptase is drawn from M-MLV, RTX, AMV-RT, or a Eubacterium rectale maturase RT (claim 7), and claim 9 lists the engineered M-MLV mutations (D200N, T306K, W313F, T330P, L603W) familiar from prime-editor optimization. Most tellingly, the integration enzyme in claim 13 is a serine integrase chosen from a long list - Bxb1, phiC31, TP901-1, and dozens of phage integrases - with claim 14 pinning the preferred Bxb1, and claim 15/16 specifying the attB/attP recognition-and-cognate pair the integrase recombines. The att sites are the "site-specific targeting elements" of the acronym: the landing pad written by prime editing and the matching site on the cargo.
What the small-edit modalities cannot do is visible in the cargo-size claims. Claim 18 recites an exogenous nucleic acid between 1,000 and 36,000 base pairs; claim 19 reaches beyond 36,000 bp. Claim 17 enumerates the payloads this enables - a CAR or TCR into a T or NK cell, a beta-hemoglobin (HBB) gene into a hematopoietic stem cell, a metabolic gene, or a gene implicated in an inherited disorder - and claim 23 puts the whole system into AAV or adenoviral delivery. These are gene-scale insertions, not single-letter corrections, and the claim language reaches that capability directly.
The CPC profile spans the hybrid mechanism: C12N 15/111 / 15/102 (editing methods), C12N 9/1276 (reverse transcriptase, the prime-editing component used to install the integrase landing site), C12N 9/22 (Cas targeting), and C12N 15/85 (the integration machinery). That cross-class signature reflects a multi-component system, not a single enzyme - and it is the structural reason the claim sits in a tier of its own.
The guide-RNA design in claim 1(b) is where prime editing and integrase biology are stitched together, and it rewards a careful read. Each guide is recited from 3' to 5' as a primer binding sequence, then a sequence complementary to one strand of an integration recognition sequence, then a target binding sequence. That ordering is the prime-editing guide (pegRNA) logic extended to a new purpose: the target binding sequence directs the nickase to the genomic site, the primer binding sequence lets the reverse transcriptase begin synthesis, and the middle segment templates the writing of an integrase landing site into the genome. Claim 1 requires at least two such guides, and claim 22 adds a nicking guide - the second-nick strategy that prime editing uses to bias repair toward installing the edit. The result is a self-contained system that first writes an attachment site and then uses it.
The integrase claims are the other half of the mechanism and are unusually concrete. Claim 13's roster of serine integrases and recombinases is long, but claim 14 names the workhorse - Bxb1 - and claims 15-16 specify the att recognition-and-cognate chemistry: an attB site written into the genome, an attP-tagged cargo, and the integrase recombining the two. Serine integrases like Bxb1 catalyze unidirectional, large-fragment recombination between att sites without needing host factors, which is precisely why they can drop a multi-kilobase payload into a defined spot - the capability the cargo-size claims (1,000-36,000 bp in claim 18, beyond 36,000 bp in claim 19) then quantify.
The reverse-transcriptase claims tie the system back to a known lineage. Claim 7 lists M-MLV among the RT options, and claim 9 enumerates the M-MLV mutations D200N, T306K, W313F, T330P, and L603W - the stabilizing, processivity-enhancing changes characterized in prime-editor development. By importing an optimized prime-editor RT and pairing it with a serine integrase, the claim reads as a deliberate fusion of two mature technologies into a third capability. For a teardown, the lesson is that "PASTE" is not one enzyme but a four-component composition, and an accused large-cargo system is measured against that whole assembly, not against any single part.
For the landscape, PASTE marks a new tier above base and prime editing in the editing-modality hierarchy - integration of large payloads at defined sites. Freedom-to-operate for any whole-gene-insertion program has to consider this integrase-plus-prime-editing layer separately from the cutting, base-editing, and prime-editing estates, because it solves a problem none of those does, and because the claimed combination - nickase-RT, dual integration-aware guides, a serine integrase, and an att-tagged cargo, all in one composition - is the specific structure a competing large-cargo system would be measured against.
Comments
Loading comments…